Zhongli, Taiwan

Our 14,059 square meter Zhongli, Taiwan facility is designed for flexible, high-quality contract liquids, semi-solid and oral solid cGMP drug manufacturing. The facility offers best-in-class capabilities and access to the largest pharmaceutical markets in the world, including North America, European Union and China.